257 related articles for article (PubMed ID: 22556149)
1. Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development.
Beaudry JL; Riddell MC
Diabetes Metab Res Rev; 2012 Oct; 28(7):560-73. PubMed ID: 22556149
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development: comments on Beaudry and Riddel.
Rafacho A
Diabetes Metab Res Rev; 2014 Feb; 30(2):120-1. PubMed ID: 24500990
[No Abstract] [Full Text] [Related]
4. Response to 'letter to the editor' by Dr Rafacho.
Beaudry JL; Riddell MC
Diabetes Metab Res Rev; 2014 Feb; 30(2):122-3. PubMed ID: 24500991
[No Abstract] [Full Text] [Related]
5. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
6. [And what about diabetes?].
Cerasi E
Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
[TBL] [Abstract][Full Text] [Related]
7. Five stages of progressive β-cell dysfunction in the laboratory Nile rat model of type 2 diabetes.
Yang K; Gotzmann J; Kuny S; Huang H; Sauvé Y; Chan CB
J Endocrinol; 2016 Jun; 229(3):343-56. PubMed ID: 27068697
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids and beta-cell function.
Fichna M; Fichna P
Endokrynol Pol; 2017; 68(5):568-573. PubMed ID: 29168546
[TBL] [Abstract][Full Text] [Related]
9. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
10. Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats.
Choi SB; Jang JS; Hong SM; Jun DW; Park S
J Endocrinol; 2006 Aug; 190(2):471-82. PubMed ID: 16899580
[TBL] [Abstract][Full Text] [Related]
11. Interorgan Crosstalk Contributing to
Tanabe K; Amo-Shiinoki K; Hatanaka M; Tanizawa Y
J Diabetes Res; 2017; 2017():3605178. PubMed ID: 28168202
[TBL] [Abstract][Full Text] [Related]
12. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
13. Exogenous glucocorticoids and a high-fat diet cause severe hyperglycemia and hyperinsulinemia and limit islet glucose responsiveness in young male Sprague-Dawley rats.
Beaudry JL; D'souza AM; Teich T; Tsushima R; Riddell MC
Endocrinology; 2013 Sep; 154(9):3197-208. PubMed ID: 23766132
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in islet beta-cell compensation and failure during diabetes.
Plaisance V; Waeber G; Regazzi R; Abderrahmani A
J Diabetes Res; 2014; 2014():618652. PubMed ID: 24734255
[TBL] [Abstract][Full Text] [Related]
15. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.
Satin LS; Butler PC; Ha J; Sherman AS
Mol Aspects Med; 2015 Apr; 42():61-77. PubMed ID: 25637831
[TBL] [Abstract][Full Text] [Related]
16. The required beta cell research for improving treatment of type 2 diabetes.
Thorens B
J Intern Med; 2013 Sep; 274(3):203-14. PubMed ID: 23751050
[TBL] [Abstract][Full Text] [Related]
17. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction.
Gupta D; Krueger CB; Lastra G
Curr Diabetes Rev; 2012 Mar; 8(2):76-83. PubMed ID: 22229253
[TBL] [Abstract][Full Text] [Related]
18. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus.
Tripathy D; Chavez AO
Curr Diab Rep; 2010 Jun; 10(3):184-91. PubMed ID: 20425581
[TBL] [Abstract][Full Text] [Related]
19. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
20. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
